Clinico-pathological observation of Gaucher disease type I
Open Access
- 30 October 2024
- journal article
- Published by Dnipro State Medical University in Morphologia
- Vol. 18 (3) , 77-81
Abstract
Background. Gaucher disease is one of the most common autosomal recessive lysosomal storage diseases which characterize by accumulation of glucosylceramide in the macrophages what is leading to the formation of Gaucher cells in the bone marrow, liver, spleen, brain and other organs with the occurrence of clinical manifestations of varying severity and age of onset. Objective. To describe local and systemic changes in the organs at Gaucher disease type I for optimization of intravital and postmortem diagnostics. Material and methods. A description of autopsy case of Gaucher disease type I. Macroscopic and histological examination were performed using standard processing. Results. In a 24-year-old woman with clinically diagnosed in childhood Gaucher disease type I, who died from liver and kidney failure, pathological examination revealed the formation of characteristic Gaucher cells in the liver with hepatomegaly, fibrosis and reorganization of the liver tissue, in mesenteric lymph nodes, bones, pia mater. The disease was complicated by bilateral hydrothorax, ascites, edema-swelling of the brain tissue, small multiple acute erosions of the stomach and duodenum mucosa with minor acute gastric bleeding, anemia and thrombocytopenia. Conclusion. In the presented observation, in spite of the early diagnostics of Gaucher disease, the patient did not receive appropriate therapy, what led to the development of severe complications and death at young age.Keywords
This publication has 11 references indexed in Scilit:
- Global Epidemiology of Gaucher Disease: an Updated Systematic Review and Meta-analysisJournal of Pediatric Hematology/Oncology, 2022
- Lysosomal storage diseasesNature Reviews Disease Primers, 2018
- Exploring the patient journey to diagnosis of Gaucher disease from the perspective of 212 patients with Gaucher disease and 16 Gaucher expert physiciansMolecular Genetics and Metabolism, 2017
- Gaucher disease epidemiology and natural history: a comprehensive review of the literatureHematology, 2016
- Gaucher disease types 1 and 3: Phenotypic characterization of large populations from the ICGG Gaucher RegistryAmerican Journal of Hematology, 2015
- Velaglucerase alfa (VPRIV) enzyme replacement therapy in patients with Gaucher disease: Long‐term data from phase III clinical trialsAmerican Journal of Hematology, 2015
- Enzyme replacement therapy with velaglucerase alfa in Gaucher disease: Results from a randomized, double‐blind, multinational, Phase 3 studyAmerican Journal of Hematology, 2013
- A reappraisal of Gaucher disease—diagnosis and disease management algorithmsAmerican Journal of Hematology, 2010
- Gaucher disease: mutation and polymorphism spectrum in the glucocerebrosidase gene (GBA)Human Mutation, 2008
- Consequences of diagnostic delays in type 1 Gaucher disease: The need for greater awareness among Hematologists–Oncologists and an opportunity for early diagnosis and interventionAmerican Journal of Hematology, 2007